Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-03-09 4:45 pm Unchanged |
2021-12-31 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 1,253,958 9.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:09 pm Unchanged |
2021-12-31 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 1,253,958 9.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:12 pm Sale |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rosalind Advisors Inc. | 707,467 1.500% |
-1,900,390 (-72.87%) |
Filing History |
| 2022-02-14 3:15 pm Sale |
2021-12-31 | 13G | PLX PHARMA INC PLXPQ |
Rosalind Advisors Inc. | 0 0.000% |
-970,425 (Position Closed) |
Filing History |
| 2022-02-11 5:14 pm Purchase |
2022-02-04 | 13G | Galera Therapeutics, Inc. GRTX |
Rosalind Advisors Inc. | 1,543,783 5.800% |
1,543,783 (New Position) |
Filing History |
| 2022-01-21 3:49 pm Purchase |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 20,174 9.970% |
9,484 (+88.71%) |
Filing History |
| 2022-01-20 4:23 pm Purchase |
2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Rosalind Advisors Inc. | 96,948 6.500% |
15,693 (+19.31%) |
Filing History |
| 2022-01-20 4:21 pm Purchase |
2021-12-31 | 13G | Myomo, Inc. MYO |
Rosalind Advisors Inc. | 553,290 8.100% |
187,390 (+51.21%) |
Filing History |
| 2022-01-06 8:15 pm Purchase |
2022-01-06 | 13G | Astria Therapeutics, Inc. ATXS |
Rosalind Advisors Inc. | 653,438 5.000% |
653,438 (New Position) |
Filing History |
| 2021-09-23 4:54 pm Purchase |
2021-09-14 | 13G | Unicycive Therapeutics, Inc. UNCY |
Rosalind Advisors Inc. | 81,256 5.600% |
81,256 (New Position) |
Filing History |
| 2021-07-08 1:30 pm Purchase |
2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors Inc. | 10,691 6.000% |
10,691 (New Position) |
Filing History |
| 2021-06-25 5:20 pm Sale |
2021-06-23 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 1,253,958 9.900% |
-713,542 (-36.27%) |
Filing History |
| 2021-05-19 2:25 pm Purchase |
2021-05-12 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rosalind Advisors Inc. | 2,607,857 5.400% |
2,607,857 (New Position) |
Filing History |
| 2021-05-19 1:37 pm Purchase |
2021-05-05 | 13G | Myomo, Inc. MYO |
Rosalind Advisors Inc. | 365,900 6.500% |
365,900 (New Position) |
Filing History |
| 2021-04-06 10:01 am Unchanged |
2021-03-31 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors Inc. | 1,967,500 9.900% |
0 (Unchanged) |
Filing History |
| 2021-01-22 5:26 pm Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
Rosalind Advisors Inc. | 179,237 4.800% |
45,904 (+34.43%) |
Filing History |
| 2021-01-22 5:26 pm Unchanged |
2020-12-31 | 13G | PLX PHARMA INC PLXPQ |
Rosalind Advisors Inc. | 970,425 6.700% |
0 (Unchanged) |
Filing History |
| 2020-12-17 7:09 pm Purchase |
2020-11-16 | 13G | PLX PHARMA INC PLXPQ |
Rosalind Advisors Inc. | 970,425 6.700% |
970,425 (New Position) |
Filing History |
| 2020-09-18 4:56 pm Purchase |
2020-09-15 | 13G | VistaGen Therapeutics, Inc. VTGN |
Rosalind Advisors Inc. | 133,333 5.400% |
133,333 (New Position) |
Filing History |